Wengang Li (Ming Li)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Regulatory T Cells

Coronary Artery Bypass

Top Venues

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Yingxue Cheng, Zhe Xi, Aobo Zhuang, Xi Li, Yue Wang, Guangting Yan, Geng Zhang, Chenhe Zhang, Kun Chen, Yang Yang Huang, Changsheng Zhou, Qing Wang, Wengang Li
A case of H-type double gallbladder anomaly: A case report. Medicine 103 (35) (2024)
Zhao Wang, Fenglin Miao, Lingwei Gu, Ruyi Zhang, Yuan Ma, Ying Li, Jialiang Zheng, Zhenhang Lin, Yilai Gao, Liyong Huang, Ye Shen, Ting Wu, Fanghong Luo, Wengang Li
Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment. ACS nano (2024)
Zhao Wang, Fenglin Miao, Lingwei Gu, Ruyi Zhang, Yuan Ma, Ying Li, Jialiang Zheng, Zhenhang Lin, Yilai Gao, Liyong Huang, Ye Shen, Ting Wu, Fanghong Luo, Wengang Li
Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment. ACS nano 18 (35) (2024)
Qiang Chen, Shuqing Zhuang, Yilin Hong, Lingtao Yang, Peng Guo, Pingli Mo, Kesong Peng, Wengang Li, Nengming Xiao, Chundong Yu
Demethylase JMJD2D induces PD-L1 expression to promote colorectal cancer immune escape by enhancing IFNGR1-STAT3-IRF1 signaling. Oncogene 41 (10) (2022)
Xiaojie Zhang, Changsheng Zhou, Fanghua Wu, Chang Gao, Qianqian Liu, Peng Lv, Ming Li, Liyong Huang, Ting Wu, Wengang Li
Bio-engineered nano-vesicles for IR820 delivery: a therapy platform for cancer by surgery and photothermal therapy. Nanoscale 14 (7) (2022)
Fu'an Xie, Dongmei Qin, Lanlan Lian, Wengang Li, Xu Kong, Xiaogang Xia, Chundong Yu, Chenghua Luo, Wengang Li
Establishment of an orthotopic perirenal space xenograft mouse model of retroperitoneal sarcoma. Cancer communications (London, England) 41 (7) (2021)